Body Fat and Other Metabolic Effects of Atazanavir and Efavirenz, Each Administered in Combination with Zidovudine plus Lamivudine, in Antiretroviral- Naive HIV-Infected Patients | Zendy

Joseph G. Jemsek | Zendy; Eduardo Arathoon | Zendy; M. Arlotti | Zendy; Cristina Fernández | Zendy; N. Sosa | Zendy; Vadim Pokrovskiy | Zendy; Alexandra Thiry | Zendy; Marine Soccodato | Zendy; Mustafa Noor | Zendy; Mauro Giordano | Zendy

Open Access

Body Fat and Other Metabolic Effects of Atazanavir and Efavirenz, Each Administered in Combination with Zidovudine plus Lamivudine, in Antiretroviral- Naive HIV-Infected Patients

Author(s) -

Joseph G. Jemsek,

Eduardo Arathoon,

M. Arlotti,

Cristina Fernández,

N. Sosa,

Vadim Pokrovskiy,

Alexandra Thiry,

Marine Soccodato,

Mustafa Noor,

Mauro Giordano

Publication year - 2005

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/498505

Subject(s) - atazanavir , efavirenz , lamivudine , lipodystrophy , medicine , zidovudine , adipose tissue , endocrinology , insulin resistance , ritonavir , indinavir , lipoatrophy , triglyceride , gastroenterology , viral load , insulin , cholesterol , virology , human immunodeficiency virus (hiv) , antiretroviral therapy , viral disease , virus , hepatitis b virus

Protease inhibitor treatment of human immunodeficiency virus (HIV)-infected individuals has been linked to the development of lipodystrophy. The effects of atazanavir on body fat distribution and related metabolic parameters were examined in antiretroviral-naive patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research